Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

February 4, 1999

Primary Completion Date

April 30, 2005

Conditions
Prostate Cancer
Interventions
DRUG

estramustine phosphate sodium

DRUG

paclitaxel

Trial Locations (28)

14642

University of Rochester Cancer Center, Rochester

19096

CCOP - MainLine Health, Wynnewood

19104

University of Pennsylvania Cancer Center, Philadelphia

19111

Fox Chase Cancer Center, Philadelphia

46202

Indiana University Hospitals, Indianapolis

Veterans Affairs Medical Center - Indianapolis (Roudebush), Indianapolis

53226

Medical College of Wisconsin, Milwaukee

53295

Veterans Affairs Medical Center - Milwaukee (Zablocki), Milwaukee

53705

Veterans Affairs Medical Center - Madison, Madison

53792

University of Wisconsin Comprehensive Cancer Center, Madison

55416

CCOP - Metro-Minnesota, Saint Louis Park

58122

CCOP - Merit Care Hospital, Fargo

60611

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago

Veterans Affairs Medical Center - Chicago (Lakeside), Chicago

61602

CCOP - Illinois Oncology Research Association, Peoria

61801

CCOP - Carle Cancer Center, Urbana

62526

CCOP - Central Illinois, Decatur

68131

CCOP - Missouri Valley Cancer Consortium, Omaha

70121

CCOP - Ochsner, New Orleans

52403-1206

CCOP - Cedar Rapids Oncology Project, Cedar Rapids

02111

New England Medical Center Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

49007-3731

CCOP - Kalamazoo, Kalamazoo

07018-1095

Veterans Affairs Medical Center - East Orange, East Orange

07601

CCOP - Northern New Jersey, Hackensack

44106-5065

Ireland Cancer Center, Cleveland

17822-2001

CCOP - Geisinger Clinical and Medical Center, Danville

0001

Pretoria Academic Hospital, Pretoria

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Eastern Cooperative Oncology Group

NETWORK

NCT00003614 - Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer | Biotech Hunter | Biotech Hunter